Patents by Inventor Mandar Shah

Mandar Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9820991
    Abstract: The present invention provides an improved novel process of manufacturing a sterile, ophthalmic pharmaceutical suspension comprising an active ingredient(s) such as carbonic anhydrase inhibitors (CAIs) wherein the said process involves solubilization, followed by controlled precipitation of carbonic anhydrase inhibitors of the right particle size, e.g., less than 10 micron, preferably less than 5 micron (D90) by varying pH with a little or no homogenization. Said process further does not require the use of any special equipment such as ball mill, milling bottle and/or jet mill. This newly improved process is simple, cost effective and efficient.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: November 21, 2017
    Assignee: SENTISS PHARMA PRIVATE LIMITED
    Inventors: Mandar Shah, Divya Pandit, Deepak Bahri
  • Publication number: 20160175317
    Abstract: The present invention provides an improved novel process of manufacturing a sterile, ophthalmic pharmaceutical suspension comprising an active ingredient(s) such as carbonic anhydrase inhibitors (CAIs) wherein the said process involves solubilization, followed by controlled precipitation of carbonic anhydrase inhibitors of the right particle size, e.g., less than 10 micron, preferably less than 5 micron (D90) by varying pH with a little or no homogenization. Said process further does not require the use of any special equipment such as ball mill, milling bottle and/or jet mill. This newly improved process is simple, cost effective and efficient.
    Type: Application
    Filed: March 2, 2016
    Publication date: June 23, 2016
    Applicant: SENTISS PHARMA PVT. LTD.
    Inventors: Mandar SHAH, Divya PANDIT, Deepak BAHRI
  • Publication number: 20080020017
    Abstract: Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular tissues during intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. The solutions preferably also have modified surface tensions that more closely resemble the surface tension of the aqueous humor.
    Type: Application
    Filed: October 4, 2007
    Publication date: January 24, 2008
    Applicant: ALCON, INC.
    Inventors: Mandar Shah, Mikhail Boukhny, William Garner, Kerry Markwardt, Uday Doshi
  • Publication number: 20070173448
    Abstract: An improved solution for use in the removal of cataractous lenses via liquefracture is described. The liquefracture solution contains a viscosity-enhancing agent to increase the residence time of the solution in the heating chamber of the liquefracture handpiece, thereby increasing the expulsion force of the solution from the handpiece (i.e., “pulse force”). An agent that releases gas when the liquefracture solution is heated in the handpiece may also be included in the solution, thereby also enhancing the pulse force of the solution upon expulsion from the handpiece. The solution preferably also contains a partially water-soluble agent that forms a temporarily insoluble precipitate when heated in a liquefracture handpiece. The precipitate acts as an abrasive agent when expelled with the liquefracture solution from the handpiece, thereby facilitating the cutting and disintegration of the cataractous lens material.
    Type: Application
    Filed: November 30, 2006
    Publication date: July 26, 2007
    Inventors: Mandar Shah, Glenn Sussman, Donald Cohen, Uday Doshi, Kerry Markwardt
  • Publication number: 20060090766
    Abstract: Disclosed are surface modified viscoelastics and methods of performing viscosurgery using polymer-containing irrigating solution to reduce cohesiveness of the viscoelastic agent at the interface, thereby improving its performance by reducing the occurrence of unintentional aspiration, especially in ocular surgery.
    Type: Application
    Filed: December 5, 2005
    Publication date: May 4, 2006
    Inventor: Mandar Shah
  • Publication number: 20060003964
    Abstract: A method of performing viscosurgery and intra-articular therapy and a dilution resistant viscoelastic composition are disclosed. One embodiment of the dilution resistant composition comprises a hyaluronate-based viscoelastic agent and a low viscosity, polymer-containing solution. The hyaluronate-based viscoelastic can be an aqueous solution sodium hyaluronate having an average molecular weight greater than 750,000 Daltons and a concentration by weight between 0.5% and 10%. The polymer-containing solution can contain a polymer selected from the group consisting of chondroitin sulfate and methylcellulose. One embodiment can comprise a polymer-containing solution containing methylcellulose at a concentration by weight from about 0.05% to about 5.0% and chondroitin sulfate at a concentration by weight from about 0.1 to about 10%.
    Type: Application
    Filed: June 30, 2004
    Publication date: January 5, 2006
    Inventors: Mandar Shah, Alan Weiner
  • Publication number: 20050148542
    Abstract: Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular tissues during intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. The solutions preferably also have modified surface tensions that more closely resemble the surface tension of the aqueous humor.
    Type: Application
    Filed: February 11, 2005
    Publication date: July 7, 2005
    Inventors: Mandar Shah, Mikhail Boukhny, William Garner, Kerry Markwardt, Uday Doshi